106 related articles for article (PubMed ID: 15154878)
21. [Heart valve calcification in patients with chronic kidney disease].
Volkov MM; Smirnov AV; Dobronravov VA; Degtereva OA; Sheviakova EV; Panina IIu; Trofimenko II
Klin Med (Mosk); 2009; 87(6):31-5. PubMed ID: 19670713
[TBL] [Abstract][Full Text] [Related]
22. Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
Ishida K; Ashizawa N; Matsumoto K; Kobashi S; Kurita N; Shigematsu T; Iwanaga T
J Bone Miner Metab; 2019 Sep; 37(5):796-804. PubMed ID: 30712064
[TBL] [Abstract][Full Text] [Related]
23. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
24. Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty.
Fokter SK; Komadina R; Repse-Fokter A; Yerby SA; Kocijancic A; Marc J
Int Orthop; 2005 Dec; 29(6):362-7. PubMed ID: 16193347
[TBL] [Abstract][Full Text] [Related]
25. Metabolic acidosis aggravation and hyperkaliemia in hemodialysis patients treated by sevelamer hydrochloride.
Sonikian MA; Pani IT; Iliopoulos AN; Koutala KG; Marioli SI; Vlassopoulos DA
Ren Fail; 2005; 27(2):143-7. PubMed ID: 15807177
[TBL] [Abstract][Full Text] [Related]
26. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of time-course changes in minerals and parathyroid hormone levels during treatment with phosphate binders in hemodialysis patients with secondary hyperparathyroidism].
Yokoyama T; Onodera Y; Mano T
Clin Calcium; 2005 Sep; 15 Suppl 1():125-30; discussion 130-1. PubMed ID: 16272644
[TBL] [Abstract][Full Text] [Related]
28. Electrocardiography and serum potassium before and after hemodialysis sessions.
Tarif N; Yamani H; Bakhsh AJ; Al-Wakeel JS; Sulaimani F; Memon NA; Al Suwaida AK
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):47-53. PubMed ID: 18087122
[TBL] [Abstract][Full Text] [Related]
29. [Atherosclerosis and vascular calcification in hemodialysis patients].
Hirasaka N; Liang XM; Mune M
Clin Calcium; 2004 Jun; 14(6):85-90. PubMed ID: 15577060
[TBL] [Abstract][Full Text] [Related]
30. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
31. Effect of etidronic acid on arterial calcification in dialysis patients.
Ariyoshi T; Eishi K; Sakamoto I; Matsukuma S; Odate T
Clin Drug Investig; 2006; 26(4):215-22. PubMed ID: 17163254
[TBL] [Abstract][Full Text] [Related]
32. Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study.
Othmane Tel H; Bakonyi G; Egresits J; Fekete BC; Fodor E; Jarai Z; Jekkel C; Nemcsik J; Szabo A; Szabo T; Kiss I; Tisler A
Hemodial Int; 2007 Oct; 11 Suppl 3():S13-21. PubMed ID: 17897105
[TBL] [Abstract][Full Text] [Related]
33. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.
Reynolds JL; Joannides AJ; Skepper JN; McNair R; Schurgers LJ; Proudfoot D; Jahnen-Dechent W; Weissberg PL; Shanahan CM
J Am Soc Nephrol; 2004 Nov; 15(11):2857-67. PubMed ID: 15504939
[TBL] [Abstract][Full Text] [Related]
34. Effect of administration of retinol and etidronate on bone histomorphometric parameters in ovariectomized rats.
Kaczmarczyk-Sedlak I; Pytlik M; Sliwińiski L; Nowińska B; Juszczyk J
Acta Pol Pharm; 2004; 61(5):383-91. PubMed ID: 15747696
[TBL] [Abstract][Full Text] [Related]
35. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
[TBL] [Abstract][Full Text] [Related]
36. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
37. [Significance of serum calcium and phosphorus control for the cardiac function in patients with long term hemodialysis].
Onoue A; Higashino Y; Ohno T; Takahashi K; Yoshimoto S; Imada A
Clin Calcium; 2005 Sep; 15 Suppl 1():138-43; discussion 143. PubMed ID: 16272646
[TBL] [Abstract][Full Text] [Related]
38. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.
Shroff RC; McNair R; Figg N; Skepper JN; Schurgers L; Gupta A; Hiorns M; Donald AE; Deanfield J; Rees L; Shanahan CM
Circulation; 2008 Oct; 118(17):1748-57. PubMed ID: 18838561
[TBL] [Abstract][Full Text] [Related]
39. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
Kranenburg G; de Jong PA; Bartstra JW; Lagerweij SJ; Lam MG; Ossewaarde-van Norel J; Risseeuw S; van Leeuwen R; Imhof SM; Verhaar HJ; de Vries JJ; Slart RHJA; Luurtsema G; den Harder AM; Visseren FLJ; Mali WP; Spiering W
J Am Coll Cardiol; 2018 Mar; 71(10):1117-1126. PubMed ID: 29519353
[TBL] [Abstract][Full Text] [Related]
40. Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy.
Huesa C; Staines KA; Millán JL; MacRae VE
Int J Mol Med; 2015 Jul; 36(1):159-65. PubMed ID: 25975272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
